R Lechler|J A Bluestone - JoVE Visualize

Showing results (201-210 of 296) with videos related to

Pageof 30

Sort By:

Journal of Immunological Methods|February 27, 2001

Development and applications of surface-linked single chain antibodies against T-cell antigensM D Griffin, P O Holman, Q Tang, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1996

Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory moleculeR N La Motte, M A Rubin, E Barr, et al.

Blood|January 15, 1996

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigensB R Blazar, P A Taylor, A Panoskaltsis-Mortari, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996

IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infectionH Nishimura, K Hiromatsu, N Kobayashi, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989

Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cellsR Q Cron, T F Gajewski, S O Sharrow, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995

An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicityM L Alegre, J Y Tso, H A Sattar, et al.

Diabetes|March 1, 1992

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibodyK C Herold, J A Bluestone, A G Montag, et al.

Science (New York, N.Y.)|August 18, 1989

Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimerL A Matis, A M Fry, R Q Cron, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997

Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathwayE S Woodle, D M Smith, J A Bluestone, et al.

Transplantation|August 1, 1991

Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodiesE S Woodle, J R Thistlethwaite, L K Jolliffe, et al.

Pageof 30

Showing results (201-210 of 296) with videos related to

Sort By:

Pageof 30

Journal of Immunological Methods|February 27, 2001

Development and applications of surface-linked single chain antibodies against T-cell antigensM D Griffin, P O Holman, Q Tang, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1996

Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory moleculeR N La Motte, M A Rubin, E Barr, et al.

Blood|January 15, 1996

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigensB R Blazar, P A Taylor, A Panoskaltsis-Mortari, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996

IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infectionH Nishimura, K Hiromatsu, N Kobayashi, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989

Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cellsR Q Cron, T F Gajewski, S O Sharrow, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995

An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicityM L Alegre, J Y Tso, H A Sattar, et al.

Diabetes|March 1, 1992

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibodyK C Herold, J A Bluestone, A G Montag, et al.

Science (New York, N.Y.)|August 18, 1989

Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimerL A Matis, A M Fry, R Q Cron, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997

Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathwayE S Woodle, D M Smith, J A Bluestone, et al.

Transplantation|August 1, 1991

Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodiesE S Woodle, J R Thistlethwaite, L K Jolliffe, et al.

Pageof 30